CSIA
MRK icon

Charles Schwab Investment Advisory’s Merck MRK Stock Holding History

Charles Schwab Investment Advisory’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,979
Closed -$261K – 54
2024
Q1 		$261K Buy
1,979
+18
+0.9% +$2.22K ﹤0.01% 97
2023
Q4 		$214K Buy
+1,961
New +$204K ﹤0.01% 111

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab Investment Advisory's MRK Position: Q2 2024 in Review

Charles Schwab Investment Advisory sold out of Merck (MRK) in Q2 2024, closing a stake of 1,979 shares — an estimated $261K sold.

Charles Schwab Investment Advisory first reported a position in MRK in Q4 2023 and held it in 2 quarters. The position peaked at $261K in Q1 2024. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Charles Schwab Investment Advisory reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab Investment Advisory sold 1,979 Merck shares in Q2 2024, an estimated $261K.
  • Charles Schwab Investment Advisory first reported a position in Merck in Q4 2023 and held it in 2 quarters.
  • Charles Schwab Investment Advisory's Merck position peaked at $261K in Q1 2024.
  • 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Charles Schwab Investment Advisory's 13F filing for Q2 2024.